These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33145028)

  • 1. Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.
    Shugg T; Pasternak AL; London B; Luzum JA
    NPJ Genom Med; 2020; 5():48. PubMed ID: 33145028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical pharmacogenetic recommendations across therapeutic areas.
    Shugg T; Pasternak AL; Luzum JA
    Pharmacogenet Genomics; 2022 Feb; 32(2):51-59. PubMed ID: 34412102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
    Pritchard D; Patel JN; Stephens LE; McLeod HL
    Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2022 Oct; 24(10):1051-1063. PubMed ID: 35931343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Turner AJ; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2024 Jul; ():. PubMed ID: 39032821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.
    Deb S; Hopefl R; Reeves AA; Cvetkovic D
    Medicines (Basel); 2024 Feb; 11(3):. PubMed ID: 38535119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2023 Sep; 25(9):619-629. PubMed ID: 37419245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.
    Bright D; Saadeh C; DeVuyst-Miller S; Sohn M; Choker A; Langerveld A
    Pharmgenomics Pers Med; 2020; 13():719-724. PubMed ID: 33328756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
    Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
    Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic biomarkers for predicting drug response.
    Bank PC; Swen JJ; Guchelaar HJ
    Expert Rev Mol Diagn; 2014 Jul; 14(6):723-35. PubMed ID: 24857685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of Pharmacogenomics Information in Drug Labels Approved by Different Agencies and its Ethical Implications.
    Güner MD; Ekmekci PE; Kurtoglu B
    Curr Drug Saf; 2022; 17(1):47-53. PubMed ID: 34315387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.
    Shahabi P; Dubé MP
    Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Pharmacogenomics in Everyday Clinical Settings.
    Bank PCD; Swen JJ; Guchelaar HJ
    Adv Pharmacol; 2018; 83():219-246. PubMed ID: 29801576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics research and clinical implementation in Brazil.
    Rodrigues-Soares F; Suarez-Kurtz G
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):538-549. PubMed ID: 30589990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services.
    Pasternak AL; Ward K; Irwin M; Okerberg C; Hayes D; Fritsche L; Zoellner S; Virzi J; Choe HM; Ellingrod V
    Clin Transl Sci; 2023 Feb; 16(2):292-304. PubMed ID: 36510710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S.
    Haga SB
    Pharmacy (Basel); 2023 Sep; 11(5):. PubMed ID: 37736916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of pharmacogenomics in regulatory science: a product life cycle review.
    Tan-Koi WC; Leow PC; Teo YY
    Pharmacogenomics J; 2018 May; 18(3):359-366. PubMed ID: 29205206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.
    Surh LC; Pacanowski MA; Haga SB; Hobbs S; Lesko LJ; Gottlieb S; Papaluca-Amati M; Patterson SD; Hughes AR; Kim MJ; Close SL; Mosteller M; Zineh I; Dechairo B; Cohen NA
    Pharmacogenomics; 2010 Dec; 11(12):1637-47. PubMed ID: 21142906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.